Agilent, GKSB-965, AdvanceBio 2-AB Verification Standard

AdvanceBio 2-AB Verification Standard. Library of Human IgG N-linked glycans whose reducing termini are derivatized with the fluorescent dye, 2-AB (2-aminobenzamide). Labeled glycans were released using GlykoPrep from the same lot of material that is contained in the Human IgG glycoprotein control vials (WS0162) included in the packaging. Intended for use as a verification standard for the GlykoPrep platform.

Specifications:
Label: 2-AB
Unit: 200 pmol

**********The following product description is generated by AI and is for reference only. If you have any questions, please contact customer service.**********
The AdvanceBio 2-AB Verification Standard is designed to deliver robust, reproducible performance for glycan analysis in biopharmaceutical and life science research. This high-quality standard is composed of well-characterized, 2-aminobenzamide (2-AB) labeled glycans, making it ideal for the verification and validation of glycan labeling, separation, and detection workflows. It is particularly useful in supporting the development and quality control of therapeutic proteins and monoclonal antibodies where precise glycan profiling is critical.

Researchers can utilize this standard to calibrate and qualify their analytical systems, ensuring accurate migration times, optimal sensitivity, and reliable performance in both routine and advanced glycan analyses. It is compatible with a wide range of liquid chromatography and mass spectrometry platforms, including Agilent’s AdvanceBio LC columns and 1290 Infinity II LC systems. This product also complements comprehensive glycan analysis kits and workflows offered by Agilent and integrates seamlessly with automated and high-throughput analytical pipelines.

By providing confidence in system suitability and method precision, this verification standard helps laboratories comply with regulatory requirements and maintain high analytical standards across research, development, and quality assurance applications in biopharma and glycoscience laboratories.